Determining donor‐specific antibody C1q‐binding ability improves the prediction of antibody‐mediated rejection in human leucocyte antigen‐incompatible kidney transplantation
Summary Detrimental impact of preformed donor‐specific antibodies (DSAs) against human leucocyte antigens on outcomes after kidney transplantation are well documented, however, the value of their capacity to bind complement for predicting antibody‐mediated rejection (AMR) and graft survival still ne...
Saved in:
Published in | Transplant international Vol. 30; no. 4; pp. 347 - 359 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Blackwell Publishing Ltd
01.04.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Summary
Detrimental impact of preformed donor‐specific antibodies (DSAs) against human leucocyte antigens on outcomes after kidney transplantation are well documented, however, the value of their capacity to bind complement for predicting antibody‐mediated rejection (AMR) and graft survival still needs to be confirmed. We aimed to study DSA characteristics (strength and C1q binding) that might distinguish harmful DSA from clinically irrelevant ones. We retrospectively studied 60 kidney‐transplanted patients with preformed DSA detected by single antigen bead (SAB) assays (IgG and C1q kits), from a cohort of 517 kidney graft recipients (124 with detectable anti‐HLA antibodies). Patients were divided into DSA strength (MFI < vs. ≥ 15 000) and C1q‐binding ability. AMR frequency was high (30%) and it increased with DSA strength (P = 0.002) and C1q+ DSA (P < 0.001). The performance of DSA C1q‐binding ability as a predictor of AMR was better than DSA strength (diagnostic odds ratio 16.3 vs. 6.4, respectively). Furthermore, a multivariable logistic regression showed that C1q+ DSA was a risk factor for AMR (OR = 16.80, P = 0.001), while high MFI DSAs were not. Graft survival was lower in high MFI C1q+ DSA in comparison with patients with C1q− high or low MFI DSA (at 6 years, 38%, 83% and 80%, respectively; P = 0.001). Both DSA strength and C1q‐binding ability assessment seem valuable for improving pretransplant risk assessment. Since DSA C1q‐binding ability was a better predictor of AMR and correlated with graft survival, C1q‐SAB may be a particularly useful tool. |
---|---|
AbstractList | Summary Detrimental impact of preformed donor-specific antibodies (DSAs) against human leucocyte antigens on outcomes after kidney transplantation are well documented, however, the value of their capacity to bind complement for predicting antibody-mediated rejection (AMR) and graft survival still needs to be confirmed. We aimed to study DSA characteristics (strength and C1q binding) that might distinguish harmful DSA from clinically irrelevant ones. We retrospectively studied 60 kidney-transplanted patients with preformed DSA detected by single antigen bead (SAB) assays (IgG and C1q kits), from a cohort of 517 kidney graft recipients (124 with detectable anti-HLA antibodies). Patients were divided into DSA strength (MFI < vs. ≥ 15 000) and C1q-binding ability. AMR frequency was high (30%) and it increased with DSA strength (P = 0.002) and C1q+ DSA (P < 0.001). The performance of DSA C1q-binding ability as a predictor of AMR was better than DSA strength (diagnostic odds ratio 16.3 vs. 6.4, respectively). Furthermore, a multivariable logistic regression showed that C1q+ DSA was a risk factor for AMR (OR = 16.80, P = 0.001), while high MFI DSAs were not. Graft survival was lower in high MFI C1q+ DSA in comparison with patients with C1q- high or low MFI DSA (at 6 years, 38%, 83% and 80%, respectively; P = 0.001). Both DSA strength and C1q-binding ability assessment seem valuable for improving pretransplant risk assessment. Since DSA C1q-binding ability was a better predictor of AMR and correlated with graft survival, C1q-SAB may be a particularly useful tool. Summary Detrimental impact of preformed donor‐specific antibodies (DSAs) against human leucocyte antigens on outcomes after kidney transplantation are well documented, however, the value of their capacity to bind complement for predicting antibody‐mediated rejection (AMR) and graft survival still needs to be confirmed. We aimed to study DSA characteristics (strength and C1q binding) that might distinguish harmful DSA from clinically irrelevant ones. We retrospectively studied 60 kidney‐transplanted patients with preformed DSA detected by single antigen bead (SAB) assays (IgG and C1q kits), from a cohort of 517 kidney graft recipients (124 with detectable anti‐HLA antibodies). Patients were divided into DSA strength (MFI < vs. ≥ 15 000) and C1q‐binding ability. AMR frequency was high (30%) and it increased with DSA strength (P = 0.002) and C1q+ DSA (P < 0.001). The performance of DSA C1q‐binding ability as a predictor of AMR was better than DSA strength (diagnostic odds ratio 16.3 vs. 6.4, respectively). Furthermore, a multivariable logistic regression showed that C1q+ DSA was a risk factor for AMR (OR = 16.80, P = 0.001), while high MFI DSAs were not. Graft survival was lower in high MFI C1q+ DSA in comparison with patients with C1q− high or low MFI DSA (at 6 years, 38%, 83% and 80%, respectively; P = 0.001). Both DSA strength and C1q‐binding ability assessment seem valuable for improving pretransplant risk assessment. Since DSA C1q‐binding ability was a better predictor of AMR and correlated with graft survival, C1q‐SAB may be a particularly useful tool. Detrimental impact of preformed donor-specific antibodies (DSAs) against human leucocyte antigens on outcomes after kidney transplantation are well documented, however, the value of their capacity to bind complement for predicting antibody-mediated rejection (AMR) and graft survival still needs to be confirmed. We aimed to study DSA characteristics (strength and C1q binding) that might distinguish harmful DSA from clinically irrelevant ones. We retrospectively studied 60 kidney-transplanted patients with preformed DSA detected by single antigen bead (SAB) assays (IgG and C1q kits), from a cohort of 517 kidney graft recipients (124 with detectable anti-HLA antibodies). Patients were divided into DSA strength (MFI < vs. ≥ 15 000) and C1q-binding ability. AMR frequency was high (30%) and it increased with DSA strength (P = 0.002) and C1q+ DSA (P < 0.001). The performance of DSA C1q-binding ability as a predictor of AMR was better than DSA strength (diagnostic odds ratio 16.3 vs. 6.4, respectively). Furthermore, a multivariable logistic regression showed that C1q+ DSA was a risk factor for AMR (OR = 16.80, P = 0.001), while high MFI DSAs were not. Graft survival was lower in high MFI C1q+ DSA in comparison with patients with C1q- high or low MFI DSA (at 6 years, 38%, 83% and 80%, respectively; P = 0.001). Both DSA strength and C1q-binding ability assessment seem valuable for improving pretransplant risk assessment. Since DSA C1q-binding ability was a better predictor of AMR and correlated with graft survival, C1q-SAB may be a particularly useful tool. Detrimental impact of preformed donor-specific antibodies (DSAs) against human leucocyte antigens on outcomes after kidney transplantation are well documented, however, the value of their capacity to bind complement for predicting antibody-mediated rejection (AMR) and graft survival still needs to be confirmed. We aimed to study DSA characteristics (strength and C1q binding) that might distinguish harmful DSA from clinically irrelevant ones. We retrospectively studied 60 kidney-transplanted patients with preformed DSA detected by single antigen bead (SAB) assays (IgG and C1q kits), from a cohort of 517 kidney graft recipients (124 with detectable anti-HLA antibodies). Patients were divided into DSA strength (MFI < vs. greater than or equal to 15 000) and C1q-binding ability. AMR frequency was high (30%) and it increased with DSA strength (P = 0.002) and C1q+ DSA (P < 0.001). The performance of DSA C1q-binding ability as a predictor of AMR was better than DSA strength (diagnostic odds ratio 16.3 vs. 6.4, respectively). Furthermore, a multivariable logistic regression showed that C1q+ DSA was a risk factor for AMR (OR = 16.80, P = 0.001), while high MFI DSAs were not. Graft survival was lower in high MFI C1q+ DSA in comparison with patients with C1q- high or low MFI DSA (at 6 years, 38%, 83% and 80%, respectively; P = 0.001). Both DSA strength and C1q-binding ability assessment seem valuable for improving pretransplant risk assessment. Since DSA C1q-binding ability was a better predictor of AMR and correlated with graft survival, C1q-SAB may be a particularly useful tool. Detrimental impact of preformed donor-specific antibodies (DSAs) against human leucocyte antigens on outcomes after kidney transplantation are well documented, however, the value of their capacity to bind complement for predicting antibody-mediated rejection (AMR) and graft survival still needs to be confirmed. We aimed to study DSA characteristics (strength and C1q binding) that might distinguish harmful DSA from clinically irrelevant ones. We retrospectively studied 60 kidney-transplanted patients with preformed DSA detected by single antigen bead (SAB) assays (IgG and C1q kits), from a cohort of 517 kidney graft recipients (124 with detectable anti-HLA antibodies). Patients were divided into DSA strength (MFI < vs. ≥ 15 000) and C1q-binding ability. AMR frequency was high (30%) and it increased with DSA strength (P = 0.002) and C1q+ DSA (P < 0.001). The performance of DSA C1q-binding ability as a predictor of AMR was better than DSA strength (diagnostic odds ratio 16.3 vs. 6.4, respectively). Furthermore, a multivariable logistic regression showed that C1q+ DSA was a risk factor for AMR (OR = 16.80, P = 0.001), while high MFI DSAs were not. Graft survival was lower in high MFI C1q+ DSA in comparison with patients with C1q- high or low MFI DSA (at 6 years, 38%, 83% and 80%, respectively; P = 0.001). Both DSA strength and C1q-binding ability assessment seem valuable for improving pretransplant risk assessment. Since DSA C1q-binding ability was a better predictor of AMR and correlated with graft survival, C1q-SAB may be a particularly useful tool. |
Author | Castro‐Henriques, António Beirão, Idalina Malheiro, Jorge Dias, Leonídio Martins, La Salete Fonseca, Isabel Cabrita, António Tafulo, Sandra |
Author_xml | – sequence: 1 givenname: Jorge surname: Malheiro fullname: Malheiro, Jorge email: jjorgemalheiro@gmail.com organization: Unit for Multidisciplinary Investigation in Biomedicine (UMIB) – sequence: 2 givenname: Sandra orcidid: 0000-0002-3911-0245 surname: Tafulo fullname: Tafulo, Sandra organization: Centro do Sangue e Transplantação do Porto – sequence: 3 givenname: Leonídio surname: Dias fullname: Dias, Leonídio organization: Centro Hospitalar do Porto – sequence: 4 givenname: La Salete surname: Martins fullname: Martins, La Salete organization: Unit for Multidisciplinary Investigation in Biomedicine (UMIB) – sequence: 5 givenname: Isabel surname: Fonseca fullname: Fonseca, Isabel organization: Unit for Multidisciplinary Investigation in Biomedicine (UMIB) – sequence: 6 givenname: Idalina surname: Beirão fullname: Beirão, Idalina organization: Unit for Multidisciplinary Investigation in Biomedicine (UMIB) – sequence: 7 givenname: António surname: Castro‐Henriques fullname: Castro‐Henriques, António organization: Unit for Multidisciplinary Investigation in Biomedicine (UMIB) – sequence: 8 givenname: António surname: Cabrita fullname: Cabrita, António organization: Centro Hospitalar do Porto |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/27717025$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkc1u1TAQhS1URG8LC14AWWIDi7T-iWNniS4UKlVCQmUdOc6k9SWxU9spyo5H4GX6QjwJvk3pAgmJ2Yw0_s6RZ84ROnDeAUIvKTmhuU5TsCeUKcmfoA0tOSsYk_IAbUjNy4IoWR6ioxh3hBCmBHmGDvMzlYSJDbp7DwnCaJ11V7jzzodfP37GCYztrcHaJdv6bsFbepPnrXXdntOtHWxasB2n4G8h4nQNeArQWZOsd9j3j8qsGvNcJ-hwgB2sgHX4eh61wwPMxpslwb3gClzmrTN-nHTWD4C_2c7BglPQLk5DhvTe4Dl62ushwouHfoy-nn243H4qLj5_PN--uyhMKRgvOsoFq_IxDKn7HsC0QpWqrgWpJAdOBG8Z1wwqoQyvlCG9kkaXglDWEmUqfozerL55z5sZYmpGGw0M-SPg59hQpaisBK_lf6BccFmyqs7o67_QnZ-Dy4tkSkpe1zVTmXq7Uib4GAP0zRTsqMPSUNLsY29y7M197Jl99eA4t_ncj-SfnDNwugLf7QDLv52ayy_nq-VvDgbALw |
CitedBy_id | crossref_primary_10_1111_iji_12552 crossref_primary_10_1016_j_trim_2022_101566 crossref_primary_10_3389_fimmu_2021_796260 crossref_primary_10_1093_ndt_gfad149 crossref_primary_10_1186_s12882_019_1625_2 crossref_primary_10_4103_ijot_ijot_28_21 crossref_primary_10_1097_TP_0000000000004262 crossref_primary_10_1016_j_humimm_2017_07_011 crossref_primary_10_1002_advs_202202633 crossref_primary_10_1097_MOT_0000000000000454 crossref_primary_10_1016_j_tracli_2017_06_025 crossref_primary_10_1111_tan_13581 crossref_primary_10_1111_tri_13327 crossref_primary_10_1016_j_trre_2024_100842 crossref_primary_10_1111_tri_12933 crossref_primary_10_3390_jcm12041312 crossref_primary_10_3390_jcm12062335 crossref_primary_10_3389_fimmu_2023_1265796 crossref_primary_10_1111_tri_13663 crossref_primary_10_1371_journal_pmed_1002572 crossref_primary_10_3389_fimmu_2017_01310 crossref_primary_10_1016_j_transproceed_2018_03_056 crossref_primary_10_2215_CJN_00700117 crossref_primary_10_1111_nep_13239 crossref_primary_10_1016_j_ekir_2018_03_015 crossref_primary_10_3390_pathogens10010004 crossref_primary_10_1111_tan_15572 crossref_primary_10_3390_jcm9020375 crossref_primary_10_1016_j_kint_2021_01_027 crossref_primary_10_1016_j_xcrm_2022_100818 crossref_primary_10_3389_fimmu_2019_01712 crossref_primary_10_1097_TP_0000000000003080 crossref_primary_10_1016_j_trim_2021_101362 crossref_primary_10_1016_j_trim_2018_03_002 |
Cites_doi | 10.1097/TP.0b013e3181dc13e7 10.1097/TP.0000000000000511 10.1111/j.1600-6143.2010.03093.x 10.1111/j.1600-6143.2009.02985.x 10.1097/TP.0b013e31827a19cc 10.1111/tri.12000 10.1097/01.TP.0000441091.47464.c6 10.1016/j.humimm.2013.06.022 10.1681/ASN.2009101065 10.1016/j.humimm.2009.05.007 10.1172/JCI72273 10.1097/TP.0b013e3182743cfa 10.1097/TP.0000000000000191 10.1681/ASN.2012070664 10.1097/TP.0b013e31819d17b0 10.1111/j.1600-6143.2009.02987.x 10.1016/j.trim.2015.01.002 10.1111/j.1399-0012.2012.01637.x 10.1097/TP.0000000000000315 10.1016/j.humimm.2009.04.011 10.1111/j.1600-6143.2012.04291.x 10.1016/j.trim.2013.07.002 10.1097/MOT.0b013e3283614c5a 10.7326/0003-4819-145-4-200608150-00004 10.1111/j.1600-6143.2011.03640.x 10.1097/TP.0b013e3182888db6 10.1111/j.1600-6143.2011.03985.x 10.1097/TP.0000000000000203 10.1056/NEJMoa1302506 10.1016/S0895-4356(03)00177-X 10.1111/ajt.12807 10.1097/TP.0b013e31822872dd 10.1097/MOT.0000000000000040 |
ContentType | Journal Article |
Copyright | 2016 Steunstichting ESOT 2016 Steunstichting ESOT. Copyright © 2017 Steunstichting ESOT. Published by John Wiley & Sons Ltd |
Copyright_xml | – notice: 2016 Steunstichting ESOT – notice: 2016 Steunstichting ESOT. – notice: Copyright © 2017 Steunstichting ESOT. Published by John Wiley & Sons Ltd |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QO 7T5 8FD FR3 H94 K9. P64 7X8 |
DOI | 10.1111/tri.12873 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Biotechnology Research Abstracts Immunology Abstracts Technology Research Database Engineering Research Database AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Biotechnology Research Abstracts Technology Research Database AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts Engineering Research Database Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitleList | Biotechnology Research Abstracts MEDLINE AIDS and Cancer Research Abstracts MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1432-2277 |
EndPage | 359 |
ExternalDocumentID | 4320727931 10_1111_tri_12873 27717025 TRI12873 |
Genre | article Journal Article |
GroupedDBID | --- .3N .86 .GA .GJ .Y3 05W 10A 123 1OB 1OC 1SB 2.D 24P 28- 29Q 2JY 2VQ 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5HH 5LA 5QI 5RE 5VS 66C 6NX 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 9T4 A01 A03 AAESR AAEVG AAFWJ AAHHS AAIAL AAONW AAZKR ABCQN ABCUV ABEML ABJNI ABLJU ABMNI ABOCM ABPVW ACAHQ ACBWZ ACCFJ ACGFS ACIWK ACMXC ACPOU ACPRK ACSCC ACXQS ADBBV ADEOM ADIMF ADINQ ADIYS ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN AEEZP AEFIE AEIMD AENEX AEQDE AEUQT AFBPY AFEBI AFEXP AFGKR AFLOW AFPKN AFPWT AFRAH AFZJQ AHACP AHBYD AHEFC AHMBA AHSBF AIACR AIURR AIWBW AJAOE AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS AMBMR AMKLP AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BBWZM BDRZF BGNMA BHBCM BMXJE BROTX BRXPI BY8 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DL5 DPXWK DR2 DRFUL DRMAN DRSTM DU5 EBS EJD EMB EMOBN EX3 F00 F01 F04 F5P FEDTE FUBAC G-S G.N GODZA GROUPED_DOAJ H.X HF~ HG6 HVGLF HZI HZ~ I09 IHE IX1 J0M K48 KBYEO KDC KOV KOW LAS LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M4Y MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NDZJH NF~ NQS NU0 O66 O9- O93 O9G O9I OIG OK1 OVD P19 P2P P2W P2X P2Z P4B P4D PALCI PGMZT PQQKQ Q.N Q11 QB0 QOK QOS R.K R4E RIG RJQFR ROL RPM RPX RSV RX1 S26 S28 SDE SDH SDM SMD SUPJJ SV3 T16 TEORI TSK TSV U2A UB1 VC2 W2D W8V W99 WBKPD WHWMO WIB WIH WIJ WIK WJK WOHZO WOW WQJ WRC WUP WVDHM WXI XG1 ZZTAW ~EX ~IA ~WT AAYZH CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QO 7T5 8FD FR3 H94 K9. P64 7X8 |
ID | FETCH-LOGICAL-c4523-d13526227c09ffeecb58489950673e3053b23a2e658c368c0f87ca45012b08c63 |
IEDL.DBID | DR2 |
ISSN | 0934-0874 |
IngestDate | Fri Aug 16 04:26:31 EDT 2024 Sun Jul 21 06:24:06 EDT 2024 Thu Oct 10 22:09:00 EDT 2024 Fri Aug 23 02:51:35 EDT 2024 Tue Oct 15 23:55:42 EDT 2024 Sat Aug 24 00:50:36 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | C1q-binding antibodies donor-specific antibodies kidney transplantation antibody-mediated rejection |
Language | English |
License | 2016 Steunstichting ESOT. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4523-d13526227c09ffeecb58489950673e3053b23a2e658c368c0f87ca45012b08c63 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0002-3911-0245 |
PMID | 27717025 |
PQID | 1877399928 |
PQPubID | 29792 |
PageCount | 13 |
ParticipantIDs | proquest_miscellaneous_1881765397 proquest_miscellaneous_1835374269 proquest_journals_1877399928 crossref_primary_10_1111_tri_12873 pubmed_primary_27717025 wiley_primary_10_1111_tri_12873_TRI12873 |
PublicationCentury | 2000 |
PublicationDate | April 2017 |
PublicationDateYYYYMMDD | 2017-04-01 |
PublicationDate_xml | – month: 04 year: 2017 text: April 2017 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: Groningen |
PublicationTitle | Transplant international |
PublicationTitleAlternate | Transpl Int |
PublicationYear | 2017 |
Publisher | Blackwell Publishing Ltd |
Publisher_xml | – name: Blackwell Publishing Ltd |
References | 2013; 29 2010; 10 2013; 26 2009; 87 2013; 369 2015; 99 2015; 32 2011; 11 2012; 12 2003; 56 2010; 89 2013; 18 2010; 21 2009; 70 2013; 13 2013; 95 2011; 92 2013; 74 2014; 14 2014; 19 2012; 26 2012; 23 2006; 145 2014; 98 2014; 124 2014; 97 28166393 - Transpl Int. 2017 Apr;30(4):344-346 Tait (10.1111/tri.12873-BIB0033|tri12873-cit-0033) 2013; 95 Cravedi (10.1111/tri.12873-BIB0009|tri12873-cit-0009) 2014; 124 Dunn (10.1111/tri.12873-BIB0018|tri12873-cit-0018) 2011; 11 Cornell (10.1111/tri.12873-BIB0032|tri12873-cit-0032) 2013; 18 Kannabhiran (10.1111/tri.12873-BIB0019|tri12873-cit-0019) 2015; 99 Honger (10.1111/tri.12873-BIB0010|tri12873-cit-0010) 2010; 89 Visentin (10.1111/tri.12873-BIB0028|tri12873-cit-0028) 2014; 98 Loupy (10.1111/tri.12873-BIB0014|tri12873-cit-0014) 2013; 369 Gloor (10.1111/tri.12873-BIB0025|tri12873-cit-0025) 2010; 10 Freitas (10.1111/tri.12873-BIB0029|tri12873-cit-0029) 2013; 95 Crespo (10.1111/tri.12873-BIB0013|tri12873-cit-0013) 2013; 29 Phelan (10.1111/tri.12873-BIB0003|tri12873-cit-0003) 2009; 70 Otten (10.1111/tri.12873-BIB0007|tri12873-cit-0007) 2012; 12 Lefaucheur (10.1111/tri.12873-BIB0005|tri12873-cit-0005) 2010; 21 Limaye (10.1111/tri.12873-BIB0031|tri12873-cit-0031) 2009; 87 Levey (10.1111/tri.12873-BIB0015|tri12873-cit-0015) 2006; 145 Schaub (10.1111/tri.12873-BIB0030|tri12873-cit-0030) 2014; 98 Aubert (10.1111/tri.12873-BIB0002|tri12873-cit-0002) 2009; 70 Yamanaga (10.1111/tri.12873-BIB0023|tri12873-cit-0023) 2013; 74 Bartel (10.1111/tri.12873-BIB0012|tri12873-cit-0012) 2013; 26 Glas (10.1111/tri.12873-BIB0017|tri12873-cit-0017) 2003; 56 Marfo (10.1111/tri.12873-BIB0020|tri12873-cit-0020) 2014; 98 Miura (10.1111/tri.12873-BIB0022|tri12873-cit-0022) 2012; 26 Malheiro (10.1111/tri.12873-BIB0006|tri12873-cit-0006) 2015; 32 Gebel (10.1111/tri.12873-BIB0004|tri12873-cit-0004) 2014; 14 Valenzuela (10.1111/tri.12873-BIB0008|tri12873-cit-0008) 2014; 19 Lawrence (10.1111/tri.12873-BIB0011|tri12873-cit-0011) 2013; 95 Bachler (10.1111/tri.12873-BIB0024|tri12873-cit-0024) 2010; 10 Bentall (10.1111/tri.12873-BIB0021|tri12873-cit-0021) 2013; 13 Mohan (10.1111/tri.12873-BIB0001|tri12873-cit-0001) 2012; 23 Schnaidt (10.1111/tri.12873-BIB0026|tri12873-cit-0026) 2011; 92 Sis (10.1111/tri.12873-BIB0016|tri12873-cit-0016) 2010; 10 Schwaiger (10.1111/tri.12873-BIB0027|tri12873-cit-0027) 2014; 97 |
References_xml | – volume: 95 start-page: 19 year: 2013 article-title: Consensus guidelines on the testing and clinical management issues associated with HLA and non‐HLA antibodies in transplantation publication-title: Transplantation – volume: 14 start-page: 1964 year: 2014 article-title: HLA antibody detection with solid phase assays: great expectations or expectations too great? publication-title: Am J Transplant – volume: 124 start-page: 2348 year: 2014 article-title: Complement as a multifaceted modulator of kidney transplant injury publication-title: J Clin Invest – volume: 10 start-page: 1254 year: 2010 article-title: Efficacy of induction therapy with ATG and intravenous immunoglobulins in patients with low‐level donor‐specific HLA‐antibodies publication-title: Am J Transplant – volume: 26 start-page: 121 year: 2013 article-title: Solid phase detection of C4d‐fixing HLA antibodies to predict rejection in high immunological risk kidney transplant recipients publication-title: Transpl Int – volume: 97 start-page: 1279 year: 2014 article-title: Complement component C3 activation: the leading cause of the prozone phenomenon affecting HLA antibody detection on single‐antigen beads publication-title: Transplantation – volume: 18 start-page: 327 year: 2013 article-title: Renal allograft pathology in the sensitized patient publication-title: Curr Opin Organ Transplant – volume: 19 start-page: 33 year: 2014 article-title: Antibody‐mediated graft injury: complement‐dependent and complement‐independent mechanisms publication-title: Curr Opin Organ Transplant – volume: 23 start-page: 2061 year: 2012 article-title: Donor‐specific antibodies adversely affect kidney allograft outcomes publication-title: J Am Soc Nephrol – volume: 95 start-page: 1113 year: 2013 article-title: The role of immunoglobulin‐G subclasses and C1q in de novo HLA‐DQ donor‐specific antibody kidney transplantation outcomes publication-title: Transplantation – volume: 21 start-page: 1398 year: 2010 article-title: Preexisting donor‐specific HLA antibodies predict outcome in kidney transplantation publication-title: J Am Soc Nephrol – volume: 95 start-page: 341 year: 2013 article-title: Preformed complement‐activating low‐level donor‐specific antibody predicts early antibody‐mediated rejection in renal allografts publication-title: Transplantation – volume: 32 start-page: 66 year: 2015 article-title: Analysis of preformed donor‐specific anti‐HLA antibodies characteristics for prediction of antibody‐mediated rejection in kidney transplantation publication-title: Transpl Immunol – volume: 74 start-page: 1111 year: 2013 article-title: Frequent development of subclinical chronic antibody‐mediated rejection within 1 year after renal transplantation with pre‐transplant positive donor‐specific antibodies and negative CDC crossmatches publication-title: Hum Immunol – volume: 87 start-page: 1052 year: 2009 article-title: Improved graft survival in highly sensitized patients undergoing renal transplantation after the introduction of a clinically validated flow cytometry crossmatch publication-title: Transplantation – volume: 11 start-page: 2132 year: 2011 article-title: Revisiting traditional risk factors for rejection and graft loss after kidney transplantation publication-title: Am J Transplant – volume: 26 start-page: 32 issue: Suppl 24 year: 2012 article-title: Long‐term histopathology of allografts in sensitized kidney recipients publication-title: Clin Transplant – volume: 70 start-page: 580 year: 2009 article-title: Low levels of human leukocyte antigen donor‐specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant publication-title: Hum Immunol – volume: 92 start-page: 510 year: 2011 article-title: HLA antibody specification using single‐antigen beads–a technical solution for the prozone effect publication-title: Transplantation – volume: 10 start-page: 464 year: 2010 article-title: Banff′09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups publication-title: Am J Transplant – volume: 99 start-page: 1156 year: 2015 article-title: Characteristics of circulating donor human leukocyte antigen‐specific immunoglobulin G antibodies predictive of acute antibody‐mediated rejection and kidney allograft failure publication-title: Transplantation – volume: 70 start-page: 584 year: 2009 article-title: Living donor renal transplantation in the presence of donor‐specific human leukocyte antigen antibody detected by solid‐phase assay publication-title: Hum Immunol – volume: 29 start-page: 28 year: 2013 article-title: Clinical relevance of pretransplant anti‐HLA donor‐specific antibodies: does C1q‐fixation matter? publication-title: Transpl Immunol – volume: 369 start-page: 1215 year: 2013 article-title: Complement‐binding anti‐HLA antibodies and kidney‐allograft survival publication-title: N Engl J Med – volume: 12 start-page: 1618 year: 2012 article-title: Pretransplant donor‐specific HLA class‐I and ‐II antibodies are associated with an increased risk for kidney graft failure publication-title: Am J Transplant – volume: 98 start-page: 387 year: 2014 article-title: Determinants of c1q binding in the single antigen bead assay publication-title: Transplantation – volume: 89 start-page: 1471 year: 2010 article-title: C4d‐fixing capability of low‐level donor‐specific HLA antibodies is not predictive for early antibody‐mediated rejection publication-title: Transplantation – volume: 145 start-page: 247 year: 2006 article-title: Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate publication-title: Ann Intern Med – volume: 10 start-page: 582 year: 2010 article-title: Baseline donor‐specific antibody levels and outcomes in positive crossmatch kidney transplantation publication-title: Am J Transplant – volume: 56 start-page: 1129 year: 2003 article-title: The diagnostic odds ratio: a single indicator of test performance publication-title: J Clin Epidemiol – volume: 98 start-page: 1082 year: 2014 article-title: Pretransplant immunologic risk assessment of kidney transplant recipients with donor‐specific anti‐human leukocyte antigen antibodies publication-title: Transplantation – volume: 98 start-page: 625 year: 2014 article-title: Deciphering complement interference in anti‐human leukocyte antigen antibody detection with flow beads assays publication-title: Transplantation – volume: 13 start-page: 76 year: 2013 article-title: Five‐year outcomes in living donor kidney transplants with a positive crossmatch publication-title: Am J Transplant – volume: 89 start-page: 1471 year: 2010 ident: 10.1111/tri.12873-BIB0010|tri12873-cit-0010 article-title: C4d-fixing capability of low-level donor-specific HLA antibodies is not predictive for early antibody-mediated rejection publication-title: Transplantation doi: 10.1097/TP.0b013e3181dc13e7 contributor: fullname: Honger – volume: 99 start-page: 1156 year: 2015 ident: 10.1111/tri.12873-BIB0019|tri12873-cit-0019 article-title: Characteristics of circulating donor human leukocyte antigen-specific immunoglobulin G antibodies predictive of acute antibody-mediated rejection and kidney allograft failure publication-title: Transplantation doi: 10.1097/TP.0000000000000511 contributor: fullname: Kannabhiran – volume: 10 start-page: 1254 year: 2010 ident: 10.1111/tri.12873-BIB0024|tri12873-cit-0024 article-title: Efficacy of induction therapy with ATG and intravenous immunoglobulins in patients with low-level donor-specific HLA-antibodies publication-title: Am J Transplant doi: 10.1111/j.1600-6143.2010.03093.x contributor: fullname: Bachler – volume: 10 start-page: 582 year: 2010 ident: 10.1111/tri.12873-BIB0025|tri12873-cit-0025 article-title: Baseline donor-specific antibody levels and outcomes in positive crossmatch kidney transplantation publication-title: Am J Transplant doi: 10.1111/j.1600-6143.2009.02985.x contributor: fullname: Gloor – volume: 95 start-page: 19 year: 2013 ident: 10.1111/tri.12873-BIB0033|tri12873-cit-0033 article-title: Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation publication-title: Transplantation doi: 10.1097/TP.0b013e31827a19cc contributor: fullname: Tait – volume: 26 start-page: 121 year: 2013 ident: 10.1111/tri.12873-BIB0012|tri12873-cit-0012 article-title: Solid phase detection of C4d-fixing HLA antibodies to predict rejection in high immunological risk kidney transplant recipients publication-title: Transpl Int doi: 10.1111/tri.12000 contributor: fullname: Bartel – volume: 97 start-page: 1279 year: 2014 ident: 10.1111/tri.12873-BIB0027|tri12873-cit-0027 article-title: Complement component C3 activation: the leading cause of the prozone phenomenon affecting HLA antibody detection on single-antigen beads publication-title: Transplantation doi: 10.1097/01.TP.0000441091.47464.c6 contributor: fullname: Schwaiger – volume: 74 start-page: 1111 year: 2013 ident: 10.1111/tri.12873-BIB0023|tri12873-cit-0023 article-title: Frequent development of subclinical chronic antibody-mediated rejection within 1 year after renal transplantation with pre-transplant positive donor-specific antibodies and negative CDC crossmatches publication-title: Hum Immunol doi: 10.1016/j.humimm.2013.06.022 contributor: fullname: Yamanaga – volume: 21 start-page: 1398 year: 2010 ident: 10.1111/tri.12873-BIB0005|tri12873-cit-0005 article-title: Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation publication-title: J Am Soc Nephrol doi: 10.1681/ASN.2009101065 contributor: fullname: Lefaucheur – volume: 70 start-page: 584 year: 2009 ident: 10.1111/tri.12873-BIB0003|tri12873-cit-0003 article-title: Living donor renal transplantation in the presence of donor-specific human leukocyte antigen antibody detected by solid-phase assay publication-title: Hum Immunol doi: 10.1016/j.humimm.2009.05.007 contributor: fullname: Phelan – volume: 124 start-page: 2348 year: 2014 ident: 10.1111/tri.12873-BIB0009|tri12873-cit-0009 article-title: Complement as a multifaceted modulator of kidney transplant injury publication-title: J Clin Invest doi: 10.1172/JCI72273 contributor: fullname: Cravedi – volume: 95 start-page: 341 year: 2013 ident: 10.1111/tri.12873-BIB0011|tri12873-cit-0011 article-title: Preformed complement-activating low-level donor-specific antibody predicts early antibody-mediated rejection in renal allografts publication-title: Transplantation doi: 10.1097/TP.0b013e3182743cfa contributor: fullname: Lawrence – volume: 98 start-page: 1082 year: 2014 ident: 10.1111/tri.12873-BIB0020|tri12873-cit-0020 article-title: Pretransplant immunologic risk assessment of kidney transplant recipients with donor-specific anti-human leukocyte antigen antibodies publication-title: Transplantation doi: 10.1097/TP.0000000000000191 contributor: fullname: Marfo – volume: 23 start-page: 2061 year: 2012 ident: 10.1111/tri.12873-BIB0001|tri12873-cit-0001 article-title: Donor-specific antibodies adversely affect kidney allograft outcomes publication-title: J Am Soc Nephrol doi: 10.1681/ASN.2012070664 contributor: fullname: Mohan – volume: 87 start-page: 1052 year: 2009 ident: 10.1111/tri.12873-BIB0031|tri12873-cit-0031 article-title: Improved graft survival in highly sensitized patients undergoing renal transplantation after the introduction of a clinically validated flow cytometry crossmatch publication-title: Transplantation doi: 10.1097/TP.0b013e31819d17b0 contributor: fullname: Limaye – volume: 10 start-page: 464 year: 2010 ident: 10.1111/tri.12873-BIB0016|tri12873-cit-0016 article-title: Banff′09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups publication-title: Am J Transplant doi: 10.1111/j.1600-6143.2009.02987.x contributor: fullname: Sis – volume: 32 start-page: 66 year: 2015 ident: 10.1111/tri.12873-BIB0006|tri12873-cit-0006 article-title: Analysis of preformed donor-specific anti-HLA antibodies characteristics for prediction of antibody-mediated rejection in kidney transplantation publication-title: Transpl Immunol doi: 10.1016/j.trim.2015.01.002 contributor: fullname: Malheiro – volume: 26 start-page: 32 issue: Suppl 24 year: 2012 ident: 10.1111/tri.12873-BIB0022|tri12873-cit-0022 article-title: Long-term histopathology of allografts in sensitized kidney recipients publication-title: Clin Transplant doi: 10.1111/j.1399-0012.2012.01637.x contributor: fullname: Miura – volume: 98 start-page: 625 year: 2014 ident: 10.1111/tri.12873-BIB0028|tri12873-cit-0028 article-title: Deciphering complement interference in anti-human leukocyte antigen antibody detection with flow beads assays publication-title: Transplantation doi: 10.1097/TP.0000000000000315 contributor: fullname: Visentin – volume: 70 start-page: 580 year: 2009 ident: 10.1111/tri.12873-BIB0002|tri12873-cit-0002 article-title: Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant publication-title: Hum Immunol doi: 10.1016/j.humimm.2009.04.011 contributor: fullname: Aubert – volume: 13 start-page: 76 year: 2013 ident: 10.1111/tri.12873-BIB0021|tri12873-cit-0021 article-title: Five-year outcomes in living donor kidney transplants with a positive crossmatch publication-title: Am J Transplant doi: 10.1111/j.1600-6143.2012.04291.x contributor: fullname: Bentall – volume: 29 start-page: 28 year: 2013 ident: 10.1111/tri.12873-BIB0013|tri12873-cit-0013 article-title: Clinical relevance of pretransplant anti-HLA donor-specific antibodies: does C1q-fixation matter? publication-title: Transpl Immunol doi: 10.1016/j.trim.2013.07.002 contributor: fullname: Crespo – volume: 18 start-page: 327 year: 2013 ident: 10.1111/tri.12873-BIB0032|tri12873-cit-0032 article-title: Renal allograft pathology in the sensitized patient publication-title: Curr Opin Organ Transplant doi: 10.1097/MOT.0b013e3283614c5a contributor: fullname: Cornell – volume: 145 start-page: 247 year: 2006 ident: 10.1111/tri.12873-BIB0015|tri12873-cit-0015 article-title: Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate publication-title: Ann Intern Med doi: 10.7326/0003-4819-145-4-200608150-00004 contributor: fullname: Levey – volume: 11 start-page: 2132 year: 2011 ident: 10.1111/tri.12873-BIB0018|tri12873-cit-0018 article-title: Revisiting traditional risk factors for rejection and graft loss after kidney transplantation publication-title: Am J Transplant doi: 10.1111/j.1600-6143.2011.03640.x contributor: fullname: Dunn – volume: 95 start-page: 1113 year: 2013 ident: 10.1111/tri.12873-BIB0029|tri12873-cit-0029 article-title: The role of immunoglobulin-G subclasses and C1q in de novo HLA-DQ donor-specific antibody kidney transplantation outcomes publication-title: Transplantation doi: 10.1097/TP.0b013e3182888db6 contributor: fullname: Freitas – volume: 12 start-page: 1618 year: 2012 ident: 10.1111/tri.12873-BIB0007|tri12873-cit-0007 article-title: Pretransplant donor-specific HLA class-I and -II antibodies are associated with an increased risk for kidney graft failure publication-title: Am J Transplant doi: 10.1111/j.1600-6143.2011.03985.x contributor: fullname: Otten – volume: 98 start-page: 387 year: 2014 ident: 10.1111/tri.12873-BIB0030|tri12873-cit-0030 article-title: Determinants of c1q binding in the single antigen bead assay publication-title: Transplantation doi: 10.1097/TP.0000000000000203 contributor: fullname: Schaub – volume: 369 start-page: 1215 year: 2013 ident: 10.1111/tri.12873-BIB0014|tri12873-cit-0014 article-title: Complement-binding anti-HLA antibodies and kidney-allograft survival publication-title: N Engl J Med doi: 10.1056/NEJMoa1302506 contributor: fullname: Loupy – volume: 56 start-page: 1129 year: 2003 ident: 10.1111/tri.12873-BIB0017|tri12873-cit-0017 article-title: The diagnostic odds ratio: a single indicator of test performance publication-title: J Clin Epidemiol doi: 10.1016/S0895-4356(03)00177-X contributor: fullname: Glas – volume: 14 start-page: 1964 year: 2014 ident: 10.1111/tri.12873-BIB0004|tri12873-cit-0004 article-title: HLA antibody detection with solid phase assays: great expectations or expectations too great? publication-title: Am J Transplant doi: 10.1111/ajt.12807 contributor: fullname: Gebel – volume: 92 start-page: 510 year: 2011 ident: 10.1111/tri.12873-BIB0026|tri12873-cit-0026 article-title: HLA antibody specification using single-antigen beads-a technical solution for the prozone effect publication-title: Transplantation doi: 10.1097/TP.0b013e31822872dd contributor: fullname: Schnaidt – volume: 19 start-page: 33 year: 2014 ident: 10.1111/tri.12873-BIB0008|tri12873-cit-0008 article-title: Antibody-mediated graft injury: complement-dependent and complement-independent mechanisms publication-title: Curr Opin Organ Transplant doi: 10.1097/MOT.0000000000000040 contributor: fullname: Valenzuela |
SSID | ssj0002850 |
Score | 2.3703547 |
Snippet | Summary
Detrimental impact of preformed donor‐specific antibodies (DSAs) against human leucocyte antigens on outcomes after kidney transplantation are well... Detrimental impact of preformed donor-specific antibodies (DSAs) against human leucocyte antigens on outcomes after kidney transplantation are well documented,... Summary Detrimental impact of preformed donor-specific antibodies (DSAs) against human leucocyte antigens on outcomes after kidney transplantation are well... |
SourceID | proquest crossref pubmed wiley |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 347 |
SubjectTerms | Adult Algorithms antibody‐mediated rejection Antigens Biomass energy Biopsy C1q‐binding antibodies Complement C1q - immunology donor‐specific antibodies Female Graft Rejection - immunology Graft Survival - immunology Histocompatibility Antigens Class I Histocompatibility Antigens Class II HLA Antigens - immunology Humans Immunoglobulin G - immunology Isoantibodies - immunology Kidney Transplantation Male Middle Aged Multivariate Analysis Odds Ratio Retrospective Studies Risk Factors Tissue Donors |
Title | Determining donor‐specific antibody C1q‐binding ability improves the prediction of antibody‐mediated rejection in human leucocyte antigen‐incompatible kidney transplantation |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Ftri.12873 https://www.ncbi.nlm.nih.gov/pubmed/27717025 https://www.proquest.com/docview/1877399928 https://search.proquest.com/docview/1835374269 https://search.proquest.com/docview/1881765397 |
Volume | 30 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbtQwELaqHiou_JS_QEEGceCSVeJ4115xQoWqIJVD1Uo9IEW2M5ZCt0nJZg_bUx-Bl-GF-iTMOD-lIBDiFiXjyNHMeL5xZj4z9gqjtvLgiziRPoll6tLYFIIcT5i5xnzChQ39g0-z_WP58WR6ssHeDL0wHT_EuOFGnhHWa3JwY5c_OXnblBNcXBUxfRKRHgGiw2vqKKHD6ayYsMs40Ur2rEJUxTOOvBmLfgOYN_FqCDh7d9jnYapdncnpZNXaibv4hcXxP7_lLrvdA1H-trOce2wDqm22ddD_ar_Pvr_rC2UwtvGirurm6vIb9WVSbRFHfZS2LtZ8N_2K920ZmmN4R_q95mXYqoAlR3jJzxt6KRkAr_04EkeFrhVEvLyBL9AJlBUPpwbyBaxwqV63EAaglaM8EUmcUQW4XQA_LYsK1rwN5OwL03VQVQ_Y8d77o939uD_jIXYSc-C4SImgXwjlkrn3AM4iIsIccEoH6AAuRpkVmRGAQMllM-0Sr5Uzcopx1SbazbKHbLOqK3jMOBhEuxb8PJGZRJRopCo8sT16q60tZMReDtrOzzsqj3xIgVABeVBAxHYGO8h7b17mqVYKgdxc6Ii9GB-jH9LPFVNBvSKZbJopagz-m4xOFXEBq4g96mxsnIlQmFgjAI3Y62Apf55ifnT4IVw8-XfRp-yWIDwSSo522GbbrOAZoqnWPg9u8wPwySLe |
link.rule.ids | 315,786,790,1382,27955,27956,46327,46751 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbtQwEB6VIgEX_guBAgZx4JJV4njXXokLaqm20O2h2kq9oCh2bCl0SUqaPSwnHoGX4YV4EmacHygIhLitdscrR57P840z8xngOUZt6azLw0i4KBSxicMs5wQ8nk0V5hPGH-jPDyezY_HmZHyyAS_7XphWH2I4cCNk-P2aAE4H0j-hvKmLEe6uMrkElxHuY4Ll7tEP8Siu_P2smLKLMFJSdLpCVMczDL0YjX6jmBcZqw85ezfgXT_ZttLkdLRq9Mh8-kXH8X-f5iZc77goe9U6zy3YsOVtuDLv3rbfga-7Xa0MhjeWV2VVf_v8hVozqbyI4ZIUusrXbCf-iN_rwvfHsFb3e80Kf1phzxkyTHZW05-SD7DKDSNxlG9cQdLLavvetgZFyfzFgWxpV7hbrxvrB6Cjoz1pSXygInC9tOy0yEu7Zo3XZ19mbRNVeReO914vdmZhd81DaASmwWEek0Y_59JEU-esNRpJEaaBY7pDx-J-lGieZNwiVzLJRJnIKWkyMcbQqiNlJskWbJZVae8DsxkSXm3dNBKJQKKYCZk7Enx0WmmdiwCe9cudnrVqHmmfBeECpH4BAtjuHSHtAH2exkpK5HJTrgJ4OvyMUKT3K1lpqxXZJONEUm_w32xULEkOWAZwr3WyYSZcYm6NHDSAF95V_jzFdHG07z88-HfTJ3B1tpgfpAf7h28fwjVO9MRXIG3DZlOv7CMkV41-7DH0HfdbJv4 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbtQwEB6VIlVc-KcEChjEgUtWieNde8UJdVm1QCtUtVIPSFHs2FLokixp9rCceARehhfiSZhxfqAgEOIWJePI0cx4vnFmPgM8xagtnXV5GAkXhSI2cZjlnByPZ1OF-YTxG_oHh5O9E_HqdHy6Ac_7XpiWH2LYcCPP8Os1Ofgydz85eVMXI1xcZXIJLotJwinzmh394I7iyh_Pihm7CCMlRUcrRGU8w9CLweg3hHkRsPqIM78G7_q5toUmZ6NVo0fm0y80jv_5MdfhaodE2YvWdG7Ahi1vwtZB96_9FnyddZUyGNxYXpVV_e3zF2rMpOIihgopdJWv2W78Ee_rwnfHsJb1e80Kv1dhzxniS7as6aVkAaxyw0gc5dtWEPKy2r63rUBRMn9sIFvYFa7V68b6AWjmKE9MEh-oBFwvLDsr8tKuWePZ2RdZ20JV3oaT-cvj3b2wO-QhNAKT4DCPiaGfc2miqXPWGo2QCJPAMZ2gY3E1SjRPMm4RKZlkokzklDSZGGNg1ZEyk-QObJZVae8CsxnCXW3dNBKJQJiYCZk7ont0WmmdiwCe9NpOly2XR9rnQKiA1CsggJ3eDtLOnc_TWEmJSG7KVQCPh8foiPR3JStttSKZZJxI6gz-m4yKJZEBywC2WxsbZsIlZtaIQAN45i3lz1NMj4_2_cW9fxd9BFtvZ_P0zf7h6_twhRM28eVHO7DZ1Cv7AJFVox96D_oOffYlrQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Determining+donor-specific+antibody+C1q-binding+ability+improves+the+prediction+of+antibody-mediated+rejection+in+human+leucocyte+antigen-incompatible+kidney+transplantation&rft.jtitle=Transplant+international&rft.au=Malheiro%2C+Jorge&rft.au=Tafulo%2C+Sandra&rft.au=Dias%2C+Leon%C3%ADdio&rft.au=Martins%2C+La+Salete&rft.date=2017-04-01&rft.issn=0934-0874&rft.volume=30&rft.issue=4&rft.spage=347&rft.epage=359&rft_id=info:doi/10.1111%2Ftri.12873&rft.externalDBID=n%2Fa&rft.externalDocID=10_1111_tri_12873 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0934-0874&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0934-0874&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0934-0874&client=summon |